SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start


From course:

CPO Biologiques

» Start this Course
(Practice similar questions for free)
Question:

Mepolizumab (Nucala)

Author: Natalia Abesada



Answer:

Anti IL-5 Ind: asthme severe refractaire a eosinophiles EI:Reactions au site d'injection, cephalees, rx allergiques locales et systemiques.


0 / 5  (0 ratings)

1 answer(s) in total